Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
Vietnam Investment Review on MSN2d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular CarcinomaLion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...
News Medical on MSN1d
The growing list of human viruses: Are we prepared for the next outbreak?Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...
The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.
HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B. Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset ...
SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback